November 2, 2017 – Five-year results from the PREVAIL Trial comparing left atrial appendage closure (LAAC) with the ...
November 02, 2017
November 2, 2017 — The treatment of in-stent restenosis (ISR) remains challenging in clinical practice. The DARE (Drug ...
November 02, 2017
November 2, 2017 — Crossing the occlusion with a guidewire is often the most challenging part of chronic total occlusion ...
November 02, 2017
November 1, 2017 — OrbusNeich reported results from the REDUCE trial in the Late-Breaking Clinical Trial session at the ...
November 01, 2017
November 1, 2017 — The double kissing (DK) crush two-stent technique was associated with a lower rate of target lesion ...
November 01, 2017
November 1, 2017 — Analytics 4 Life announced it will be presenting new clinical data on the company's ongoing Coronary ...
November 01, 2017
November 1, 2017 — Analysis of the PARTNER 2A trial and the SAPIEN-3 Intermediate Risk registry found transcatheter ...
November 01, 2017
Culprit Lesion-Only PCI Improves Outcomes for Cardiogenic Shock Patients Compared to Multivessel PCI
November 1, 2017 — Results from the prospective, randomized, multicenter CULPRIT-SHOCK trial found an initial strategy ...
November 01, 2017
October 31, 2017 — The VAMPIRE 3 study evaluated if the selective use of distal filter protection might decrease the ...
October 31, 2017
October 31, 2017 — Edwards Lifesciences Corp. announced new data demonstrating substantial economic advantages of the ...
October 31, 2017
October 31, 2017 – Thirty-day results from ABSORB IV, the largest randomized everolimus-eluting bioresorbable vascular ...
October 31, 2017
October 31, 2017 — The U.S. Food and Drug Administration (FDA) issued a warning to healthcare providers that interim ...
October 31, 2017
October 30, 2017 — New study results from the EXCEL trial comparing the quality of life (QoL) of patients with left main ...
October 30, 2017
October 30, 2017 — Entering their pre-market phase of development, Materialise is working with select U.S. and EU ...
October 30, 2017
October 27, 2017 — CeloNova BioSciences Inc. announced the U.S. Food and Drug Administration (FDA) approved expansion of ...
October 27, 2017